Phase I study of chemoradiotherapy using gemcitabine plus nab-paclitaxel for unresectable locally advanced pancreatic cancer

被引：0
作者：
Suguru Yamada
Tsutomu Fujii
Yukihiro Yokoyama
Hiroki Kawashima
Osamu Maeda
Kojiro Suzuki
Tohru Okada
Eizaburo Ono
Junpei Yamaguchi
Nao Takano
Hideki Takami
Masamichi Hayashi
Yukiko Niwa
Yoshiki Hirooka
Yoshiyuki Ito
Shinji Naganawa
Yuichi Ando
Masato Nagino
Hidemi Goto
Yasuhiro Kodera
机构：
[1] Nagoya University Graduate School of Medicine,Department of Gastroenterological Surgery (Surgery II)
[2] University of Toyama,Department of Surgery and Science, Graduate School of Medicine and Pharmaceutical Sciences
[3] Nagoya University Graduate School of Medicine,Division of Surgical Oncology, Department of Surgery
[4] Nagoya University Graduate School of Medicine,Department of Gastroenterology and Hepatology
[5] Nagoya University Hospital,Department of Clinical Oncology and Chemotherapy
[6] Aichi Medical University,Department of Radiology
[7] Nagoya University Graduate School of Medicine,Department of Radiology
[8] Nagoya University Hospital,Department of Endoscopy
来源：
Cancer Chemotherapy and Pharmacology | 2018年 / 81卷
关键词：
Phase I study; Gemcitabine; Nab-paclitaxel; Radiation; Unresectable locally advanced pancreatic cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：815 / 821
页数：6
相关论文
共 50 条
[31]   Tumor treating fields in combination with gemcitabine or gemcitabine plus nab-paclitaxel in pancreatic cancer: Results of the PANOVA phase 2 study [J].
Rivera, Fernando ;
Benavides, Manuel ;
Gallego, Javier ;
Guillen-Ponce, Carmen ;
Lopez-Martin, Jose ;
Kung, Marc .
PANCREATOLOGY, 2019, 19 (01) :64-72
[32]   Phase 1 trial of enzalutamide in combination with gemcitabine and nab-paclitaxel for the treatment of advanced pancreatic cancer [J].
Mahipal, Amit ;
Tella, Sri Harsha ;
Kommalapati, Anuhya ;
Goyal, Gaurav ;
Soares, Heloisa ;
Neuger, Anthony ;
Copolla, Domenico ;
Kim, Jongphil ;
Kim, Richard .
INVESTIGATIONAL NEW DRUGS, 2019, 37 (03) :473-481
[33]   Phase 1 trial of enzalutamide in combination with gemcitabine and nab-paclitaxel for the treatment of advanced pancreatic cancer [J].
Amit Mahipal ;
Sri Harsha Tella ;
Anuhya Kommalapati ;
Gaurav Goyal ;
Heloisa Soares ;
Anthony Neuger ;
Domenico Copolla ;
Jongphil Kim ;
Richard Kim .
Investigational New Drugs, 2019, 37 :473-481
[34]   Gemcitabine plus nab-paclitaxel for pancreatic cancer and interstitial lung disease: A nationwide longitudinal study [J].
Saito, Kei ;
Michihata, Nobuaki ;
Hamada, Tsuyoshi ;
Jo, Taisuke ;
Matsui, Hiroki ;
Fushimi, Kiyohide ;
Nakai, Yousuke ;
Yasunaga, Hideo ;
Fujishiro, Mitsuhiro .
CANCER SCIENCE, 2023, 114 (10) :3996-4005
[35]   Comparison of efficacy and toxicity of FOLFIRINOX and gemcitabine with nab-paclitaxel in unresectable pancreatic cancer [J].
Muranaka, Tetsuhito ;
Kuwatani, Masaki ;
Komatsu, Yoshito ;
Sawada, Kentaro ;
Nakatsumi, Hiroshi ;
Kawamoto, Yasuyuki ;
Yuki, Satoshi ;
Kubota, Yoshimasa ;
Kubo, Kimitoshi ;
Kawahata, Shuhei ;
Kawakubo, Kazumichi ;
Kawakami, Hiroshi ;
Sakamoto, Naoya .
JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2017, 8 (03) :566-571
[36]   Phase II clinical trial of nab-paclitaxel plus gemcitabine in elderly patients with previously untreated locally advanced or metastatic pancreatic adenocarcinoma: the BIBABRAX study [J].
Jaime Feliu ;
Mónica Jorge Fernández ;
Teresa Macarulla ;
Bartomeu Massuti ;
Ana Albero ;
José Federico González González ;
Guillermo Quintero-Aldana ;
Juan Ignacio Delgado-Mingorance ;
Ana Fernández Montes ;
Carmen García Piernavieja ;
Manuel Valladares-Ayerbes ;
Ana María López Muñoz ;
Rebeca Mondéjar Solís ;
Pilar Vicente ;
Esther Casado Gonzalez ;
Irene González Cebrián ;
Guillermo López-Vivanco .
Cancer Chemotherapy and Pharmacology, 2021, 87 :543-553
[37]   A Real-World Comparison of FOLFIRINOX, Gemcitabine Plus nab-Paclitaxel, and Gemcitabine in Advanced Pancreatic Cancers [J].
Wang, Ying ;
Camateros, Pierre ;
Cheung, Winson Y. .
JOURNAL OF GASTROINTESTINAL CANCER, 2019, 50 (01) :62-68
[38]   Phase II clinical trial of nab-paclitaxel plus gemcitabine in elderly patients with previously untreated locally advanced or metastatic pancreatic adenocarcinoma: the BIBABRAX study [J].
Feliu, Jaime ;
Jorge Fernandez, Monica ;
Macarulla, Teresa ;
Massuti, Bartomeu ;
Albero, Ana ;
Gonzalez Gonzalez, Jose Federico ;
Quintero-Aldana, Guillermo ;
Ignacio Delgado-Mingorance, Juan ;
Fernandez Montes, Ana ;
Garcia Piernavieja, Carmen ;
Valladares-Ayerbes, Manuel ;
Lopez Munoz, Ana Maria ;
Mondejar Solis, Rebeca ;
Vicente, Pilar ;
Casado Gonzalez, Esther ;
Gonzalez Cebrian, Irene ;
Lopez-Vivanco, Guillermo .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2021, 87 (04) :543-553
[39]   Comparing the Efficacy and Safety of Gemcitabine plus Nab-Paclitaxel versus Gemcitabine Alone in Older Adults with Unresectable Pancreatic Cancer [J].
Kobayashi, Satoshi ;
Suzuki, Motoko ;
Ueno, Makoto ;
Maruki, Yuta ;
Okano, Naohiro ;
Todaka, Akiko ;
Ozaka, Masato ;
Tsuji, Kunihiro ;
Shioji, Kazuhiko ;
Doi, Keitaro ;
Kojima, Yasushi ;
Tsumura, Hidetaka ;
Tanaka, Kazunari ;
Higuchi, Hajime ;
Kawabe, Ken ;
Imaoka, Hiroshi ;
Yamashita, Tatsuya ;
Miwa, Haruo ;
Nagano, Hiroaki ;
Arima, Shiho ;
Hayashi, Hideyuki ;
Naganuma, Atsushi ;
Yamaguchi, Hironori ;
Hisano, Terumasa ;
Umemoto, Kumiko ;
Ishii, Shuji ;
Nakashima, Koji ;
Suzuki, Rei ;
Kitano, Yohei ;
Misumi, Toshihiro ;
Furuse, Junji ;
Ishii, Hiroshi .
ONCOLOGIST, 2022, 27 (10) :E774-E782
[40]   Low-dose gemcitabine plus nab-paclitaxel versus standard-dose gemcitabine plus nab-paclitaxel in elderly patients with metastatic pancreatic cancer: A randomized Phase II trial [J].
Kamata, Ken ;
Imai, Hajime ;
Matsumoto, Hisakazu ;
Yamashita, Yukitaka ;
Kato, Takao ;
Nishi, Katsuhisa ;
Omoto, Shunsuke ;
Minaga, Kosuke ;
Yamao, Kentaro ;
Hyodo, Tomoko ;
Im, Sung-Woon ;
Hara, Akane ;
Yoshikawa, Tomoe ;
Ishikawa, Rei ;
Okamoto, Ayana ;
Yamazaki, Tomohiro ;
Nakai, Atsushi ;
Ueshima, Kazuomi ;
Chiba, Yasutaka ;
Takenaka, Mamoru ;
Watanabe, Tomohiro ;
Kitano, Masayuki ;
Kudo, Masatoshi .
JGH OPEN, 2023, 7 (09) :659-666
12345